What is the difference between ventricular fibrillation (VF) and ventricular tachycardia (VT)?

Ventricular Fibrillation vs Ventricular Tachycardia: Key Differences

Ventricular fibrillation (VF) represents disorganized, chaotic electrical activity with no effective cardiac output, while ventricular tachycardia (VT) represents organized, rapid ventricular electrical activity that may or may not produce a pulse. 1

Fundamental Electrophysiologic Distinctions

VF Characteristics

• Disorganized electrical activity with no coordinated ventricular contraction
• Always pulseless - produces no forward blood flow
• Heart rate typically >300 beats per minute with irregular, chaotic waveforms 2
• Requires immediate unsynchronized defibrillation 1
• On ECG: irregular, chaotic waveforms with no identifiable QRS complexes

VT Characteristics

• Organized electrical activity with identifiable QRS complexes
• Can be pulseless or with pulse - this distinction is critical for management 3
• Heart rate typically >100 beats per minute but usually <300 bpm 2
• QRS duration ≥0.12 seconds (wide complex) 1
• Two main subtypes:
  • Monomorphic VT: uniform QRS morphology, usually from scar-related reentry 4, 5
  • Polymorphic VT: varying QRS morphology, behaves more like VF and requires higher energy for cardioversion 2

Clinical Presentation Algorithm

If patient has no pulse: Treat as cardiac arrest - both pulseless VT and VF receive identical treatment with immediate defibrillation 3

If patient has pulse: Determine hemodynamic stability:

• Unstable VT (hypotension, heart failure, chest pain, rate ≥150 bpm): immediate synchronized cardioversion 1
• Stable VT: obtain 12-lead ECG, consider antiarrhythmic medications (amiodarone 150 mg IV over 10 minutes or procainamide) 1, 6

Energy Requirements for Cardioversion

The electrical characteristics directly impact treatment:

• Monomorphic VT (especially <200 bpm): requires relatively low energy - 18A (70J) successful in 69% of cases 2
• Polymorphic VT: behaves like VF, requires higher energy - 25-30A (137-221J) 2
• VF: requires high energy - 25-30A with only 19-53% success at lower energies 2

Prognostic and Mechanistic Differences

Patients presenting with VT versus VF have fundamentally different electrophysiologic substrates 7, 8:

• VT patients typically have:

  • Longer ventricular activation times (181±33 ms vs 152±23 ms) 8
  • Lower ejection fractions (22% vs 27%) 8
  • More extensive structural heart disease 7
  • During follow-up: 73.5% have recurrent VT, only 18.3% develop VF 7

• VF patients typically have:

  • Shorter ventricular activation times 8
  • Better preserved ventricular function 8
  • During follow-up: 30.1% have VT, 28% have recurrent VF 7

Critical Management Pitfall

Never assume VT will "just" cardiovert easily because it's organized. Polymorphic VT requires the same aggressive energy approach as VF 2. The rhythm regularity and QRS morphology determine energy needs, not just the label "VT" versus "VF."

Transition Between Rhythms

VT can degenerate into VF, particularly when:

• VT rate is very rapid
• There is severe conduction delay (increased latency and prolonged activation time) 9
• Polymorphic VT is present 10

The key clinical takeaway: VF is always an emergency requiring immediate defibrillation. VT management depends entirely on whether the patient has a pulse - pulseless VT = treat as VF; VT with pulse = assess stability and treat accordingly.